Drug intelligence / Profile preview

tosufloxacin

Development stage
Unknown
Lead developer
Fujifilm
Modality
Small Molecules
Administration
Oral, Topical, Ophthalmic, Otic
01

Overview

Tosufloxacin is a fluoroquinolone antibiotic used to treat a wide range of infections, including skin, respiratory, urinary, gynecological, ophthalmologic, otorhinologic (ear/nose/throat), and dental/oral surgical infections[1][4][7]. It acts as a bactericidal agent by inhibiting bacterial DNA gyrase and topoisomerase IV—enzymes essential for bacterial DNA replication and transcription[4][6]. Tosufloxacin is known for its broad-spectrum antibacterial activity against both gram-positive and gram-negative bacteria. However, it has a controversial safety profile compared to other fluoroquinolones due to associations with severe thrombocytopenia (low platelet count), nephritis (kidney inflammation), and hepatotoxicity (liver toxicity)[3][4]. The drug is marketed in Japan under the brand name Ozex[3].

Brand names
Ozex
Other names
tosufloxacin tosylate monohydrate
02

Targets

DNA gyraseTopo IV (Bacterial Topoisomerase IV)

Beyond the preview

Go deeper on tosufloxacin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tosufloxacin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call